moexiprilat has been researched along with Endomyocardial Fibrosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grohé, C; Kahlert, S; Löbbert, K; Neyses, L; Stimpel, M; van Eickels, M; Vetter, H | 1 |
1 other study(ies) available for moexiprilat and Endomyocardial Fibrosis
Article | Year |
---|---|
Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cells, Cultured; Culture Media; Endomyocardial Fibrosis; Estradiol; Estrone; Female; Fibroblasts; Gene Expression; Genes, fos; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Isoquinolines; Male; Menopause; Myocardium; Rats; Sp1 Transcription Factor; Tetrahydroisoquinolines | 1998 |